| Title | Current Reviews in Clinical and Experimental Pharmacology |
| Abbreviation | Curr. Rev. Clin. Exp. Pharmacol. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3) |
| h-index | 51 |
| Overall Rank/Ranking | 15234 |
| SCImago Journal Rank (SJR) | 0.347 |
| Impact Score | 0.96 |
| Publisher | Bentham Science Publishers |
| Country | United Arab Emirates |
| ISSN | 27724328, 27724336 |
| Best Quartile | Q2 |
| Coverage History | 2021-2025 |
Current Reviews in Clinical and Experimental Pharmacology is a journal covering the technologies/fields/categories related to Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3). It is published by Bentham Science Publishers. The overall rank of Current Reviews in Clinical and Experimental Pharmacology is 15234. According to SCImago Journal Rank (SJR), this journal is ranked 0.347. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 51. The best quartile for this journal is Q2.
The ISSN of Current Reviews in Clinical and Experimental Pharmacology journal is 27724328, 27724336. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Current Reviews in Clinical and Experimental Pharmacology is cited by a total of 91 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Current Reviews in Clinical and Experimental Pharmacology is 0.96, which is computed in 2025 as per its definition. Current Reviews in Clinical and Experimental Pharmacology IF is decreased by a factor of 0.33 and approximate percentage change is -25.58% when compared to preceding year 2023, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Current Reviews in Clinical and Experimental Pharmacology is 0.96. If the same downward trend persists, Impact IF may fall in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.96 |
| 2023 | 1.29 |
| 2022 | 1.74 |
| 2021 | 2.40 |
| 2020 | 2.46 |
| 2019 | 1.79 |
| 2018 | 1.21 |
| 2017 | 1.60 |
| 2016 | 1.60 |
| 2015 | 1.68 |
| 2014 | 1.79 |
Current Reviews in Clinical and Experimental Pharmacology has an h-index of 51. It means 51 articles of this journal have more than 51 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Current Reviews in Clinical and Experimental Pharmacology is 27724328, 27724336. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Current Reviews in Clinical and Experimental Pharmacology is 15234. According to SCImago Journal Rank (SJR), this journal is ranked 0.347. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.347 |
| 2023 | 0.44 |
| 2022 | 0.406 |
| 2021 | 0.536 |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 15234 |
| 2023 | 12055 |
| 2022 | 12337 |
| 2021 | 9326 |
| 2020 | 33107 |
| 2019 | 30701 |
| 2018 | 32140 |
| 2017 | 32893 |
| 2016 | 32627 |
| 2015 | 32279 |
| 2014 | 31681 |
Current Reviews in Clinical and Experimental Pharmacology is published by Bentham Science Publishers. It's publishing house is located in United Arab Emirates. Coverage history of this journal is as following: 2021-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Current Reviews in Clinical and Experimental Pharmacology is Curr. Rev. Clin. Exp. Pharmacol.. This abbreviation ('Curr. Rev. Clin. Exp. Pharmacol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Current Reviews in Clinical and Experimental Pharmacology latest impact IF is 0.96. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 2.46 (2020) and 0.96 (2024), respectively, in the last 11 years. Moreover, its average IS is 1.68 in the previous 11 years.
The Current Reviews in Clinical and Experimental Pharmacology has an SJR (SCImago Journal Rank) of 0.347, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.536 in 2021 and the lowest being in 2020. Furthermore, the average SJR of the Current Reviews in Clinical and Experimental Pharmacology over the previous 11-year period stands at 1.68.
The latest h-index of the Current Reviews in Clinical and Experimental Pharmacology is 51.
The Current Reviews in Clinical and Experimental Pharmacology is published by the Bentham Science Publishers, with its country of publication being the United Arab Emirates.
The Current Reviews in Clinical and Experimental Pharmacology is currently ranked 15234 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 9326 in 2021 and its lowest position of 33107 in 2020.
The standard ISO4 abbreviation for the Current Reviews in Clinical and Experimental Pharmacology is Curr. Rev. Clin. Exp. Pharmacol..
Current Reviews in Clinical and Experimental Pharmacology is classified as a journal that the Bentham Science Publishers publishes.
The Current Reviews in Clinical and Experimental Pharmacology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Current Reviews in Clinical and Experimental Pharmacology is assigned the following International Standard Serial Numbers (ISSN): 27724328, 27724336.
The best quartile for the Current Reviews in Clinical and Experimental Pharmacology is Q2 (2024).
The Current Reviews in Clinical and Experimental Pharmacology coverage history can be summarized as follows: 2021-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| European Union Politics | journal | 1953 | SAGE Publications Ltd | 79 | 3.71 |
| Historia | journal | 22470 | Universidade Estadual Paulista | 9 | 0.16 |
| European Journal of Education | journal | 4974 | Wiley-Blackwell Publishing Ltd | 63 | 5.08 |
| Journal of Sociolinguistics | journal | 4415 | Wiley-Blackwell Publishing Ltd | 68 | 2.14 |
| European Surgery - Acta Chirurgica Austriaca | journal | 18136 | Springer Medizin | 25 | 0.68 |
| Proceedings of the Technical Association of the Graphic Arts, TAGA | conference and proceedings | 30903 | Technical Association of the Graphic | 8 | 0.00 |
| Proceedings of the International Semiconductor Conference, CAS | conference and proceedings | 25734 | Institute of Electrical and Electronics Engineers Inc. | 16 | 0.00 |
| Archives of the Balkan Medical Union | journal | 26504 | Balkan Medical Union | 13 | 0.20 |
| Acta Periodica Technologica | journal | 22883 | University of Novi Sad, Faculty of Technology | 22 | 0.71 |
| European Journal of Cancer, Supplement | journal | 13149 | Elsevier Ltd | 30 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.96 |
| 2023 | 1.29 |
| 2022 | 1.74 |
| 2021 | 2.40 |
| 2020 | 2.46 |
| 2019 | 1.79 |
| 2018 | 1.21 |
| 2017 | 1.60 |
| 2016 | 1.60 |
| 2015 | 1.68 |
| 2014 | 1.79 |
